[Logo - CDER] CHEMISTRY REVIEW
TEMPLATE [Logo - CDER] |
Chemistry Assessment Section
a.
Preparation...................................................
.............................................................................. |
19 |
b. Specifications............................................................................................................................... |
20 |
6. Regulatory
Specifications/Analytical Methods
.................................................................................. |
21 |
a. Drug
Substance Specifications & Tests
........................................................................................ |
21 |
b. Purity Profile................................................................................................................................ |
21 |
c. Microbiology
............................................................................................................................... |
25 |
7. Container /
Closure System For Drug Substance Storage
.................................................................... |
26 |
8. Drug Substance
Stability ................................................................................................................... |
27 |
II. DRUG PRODUCT ................................................................................................................................ |
31 |
1.
Components/Composition
.................................................................................................................. |
31 |
2. Specifications
& Methods For Drug Product Ingredients
..................................................................... |
33 |
a. Active
Ingredient(s) ..................................................................................................................... |
33 |
b. Inactive
Ingredients
..................................................................................................................... |
33 |
3. Manufacturer
................................................................................................................................... |
34 |
4. Methods of
Manufacturing and Packagingg [Packaging]
..................................................................... |
36 |
a. Production
Operations
................................................................................................................. |
39 |
b. In-Process
Controls & Tests
........................................................................................................ |
39 |
c. Reprocessing
Operations
............................................................................................................. |
39 |
5. Regulatory
Specifications and Methods For Drug Product
................................................................... |
40 |
a. Sampling
Procedures
................................................................................................................... |
40 |
b. Regulatory
Specifications And Methods
........................................................................................ |
40 |
6. Container/Closure
System
................................................................................................................. |
46 |
7. Microbiology
.................................................................................................................................... |
50 |
8. Drug Product
Stability
....................................................................................................................... |
51 |
III. INVESTIGATIONAL FORMULATIONS
............................................................................................ |
57 |
IV. ENVIRONMENTAL ASSESSMENT
................................................................................................... |
58 |
V. METHODS VALIDATION
.................................................................................................................. |
58 |
VI. LABELING
......................................................................................................................................... |
59 |
VII. ESTABLISHMENT
INSPECTION
..................................................................................................... |
61 |
VIII. DRAFT DEFICIENCY LETTER
........................................................................................................ |
62 |
Page 3 of 16
Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page